Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Òðàâìàòîëîãèÿ, îðòîïåäèÿ è ýñòåòè÷åñêàÿ õèðóðãèÿ

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 05.10.2006, 11:27
Dem Dem âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.09.2006
Ñîîáùåíèé: 15
Dem *
Òåðàôëåêñ

Èçâèíèòå, ìîæåò áûòü çäåñü óæå çàäàâàëñÿ ýòîò âîïðîñ.
Ìåíÿ èíòåðåñóåò êàê äîëãî ìîæíî ïðèíèìàòü òåðàôëåêñ?
ß ïüþ åãî óæå äâà ãîäà.
  #2  
Ñòàðûé 05.10.2006, 18:46
Àâàòàð äëÿ Sereda Andrey
Sereda Andrey Sereda Andrey âíå ôîðóìà
òðàâìàòîëîã-îðòîïåä
      
 
Ðåãèñòðàöèÿ: 04.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5,322
Ïîáëàãîäàðèëè 1,242 ðàç(à) çà 1,140 ñîîáùåíèé
Sereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðîèçâîäèòåëü ðåêîìåíäóåò ïðèíèìàòü ïðåïàðàò äëèòåëüíî.... ò.å. ïîñòîÿííî. Íå ñåêðåò, ÷òî òàêèì îáðàçîì ïîëó÷àÿ ôèíàíñîâóþ âûãîäó. Íî! Ïîìíèòå î òîì, ÷òî ïðèìåíèòåëüíî ê ýòîìó "ëåêàðñòâó" ÎÒÑÓÒÑÒÂÓÞÒ âíÿòíûå äîêàçàòåëüñòâà ýôôåêòèâíîñòè ïðè ðàçëè÷íûõ âàðèàíòàõ ïðèìåíåíèÿ. ß íèêîãäà íå íàçíà÷àþ ñâîèì ïàöèåíòàì Òåðàôëåêñ è åãî "îäíîãðóïïíèêîâ". Âðà÷è â ÑØÀ âîîáùå íå çíÿþò- ÷òî òàêîå õîíäðîïðîòåêòîð. Âîò è ä-ð Ðåðð íà ìîé íåäàâíèé âîïðîñ î òîì, ÷òî îí ïîíèìàåò ïîä õîíäðîïðîòåêòîðàìè, îòâåòèë, ÷òî õîíäðîïðîòåêòèâíîå äåéñòâèå èìïëàíòàòîâ ñèíîâèàëüíîé æèäêîñòè. ( à íå òàáëåòîê õîíäðîèòèí ñóëüôàòà è ò.ä.) Ñîáñòâåííî ãîâîðÿ ïîäîáíàÿ ïàíàöåÿ "îò ñóñòàâîâ" ïðîäàåòñÿ íàãëûì îáðàçîì (ãäå ðîññèéñêàÿ FDA?!?) íà òåððèòîðèè áûâøåãî ÑÑÑÐ. Ëó÷øå äîëîæèòå ñóòü âàøåé ïðîáëåìû ñîãëàñíî ïðàâèëàì ôîðóìà. Òîãäà ñîâåò, âîçìîæíî, áóäåò ïðàêòè÷íåå.
  #3  
Ñòàðûé 05.10.2006, 19:23
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Cool

Öèòàòà:
Ñîîáùåíèå îò Sereda Andrey
Ïðîèçâîäèòåëü ðåêîìåíäóåò ïðèíèìàòü ïðåïàðàò äëèòåëüíî.... ò.å. ïîñòîÿííî. Íå ñåêðåò, ÷òî òàêèì îáðàçîì ïîëó÷àÿ ôèíàíñîâóþ âûãîäó. Íî! Ïîìíèòå î òîì, ÷òî ïðèìåíèòåëüíî ê ýòîìó "ëåêàðñòâó" ÎÒÑÓÒÑÒÂÓÞÒ âíÿòíûå äîêàçàòåëüñòâà ýôôåêòèâíîñòè ïðè ðàçëè÷íûõ âàðèàíòàõ ïðèìåíåíèÿ. ß íèêîãäà íå íàçíà÷àþ ñâîèì ïàöèåíòàì Òåðàôëåêñ è åãî "îäíîãðóïïíèêîâ". Âðà÷è â ÑØÀ âîîáùå íå çíÿþò- ÷òî òàêîå õîíäðîïðîòåêòîð. Âîò è ä-ð Ðåðð íà ìîé íåäàâíèé âîïðîñ î òîì, ÷òî îí ïîíèìàåò ïîä õîíäðîïðîòåêòîðàìè, îòâåòèë, ÷òî õîíäðîïðîòåêòèâíîå äåéñòâèå èìïëàíòàòîâ ñèíîâèàëüíîé æèäêîñòè. ( à íå òàáëåòîê õîíäðîèòèí ñóëüôàòà è ò.ä.) Ñîáñòâåííî ãîâîðÿ ïîäîáíàÿ ïàíàöåÿ "îò ñóñòàâîâ" ïðîäàåòñÿ íàãëûì îáðàçîì (ãäå ðîññèéñêàÿ FDA?!?) íà òåððèòîðèè áûâøåãî ÑÑÑÐ. Ëó÷øå äîëîæèòå ñóòü âàøåé ïðîáëåìû ñîãëàñíî ïðàâèëàì ôîðóìà. Òîãäà ñîâåò, âîçìîæíî, áóäåò ïðàêòè÷íåå.
ß äóìàþ, ÷òî àìåðèêàíöû êîêåòíè÷àþò, êîãäà ãîâîðÿò, ÷òî íå çíàþò, ÷òî òàêîå õîíäðîïðîòåêòîðû è êàêîâà èõ ðîëü íà ðûíêå ïðåïàðàòîâ è â êëèíèêå. Ïîñêîëüêó ïðîäàþòñÿ ýòè ïðåïàðàòû â ÑØÀ âåñüìà øèðîêî, âåñüìà øèðîêî æå, íåñìîòðÿ íà ñâîþ íåêîòîðóþ ñïîðíîñòü è îòíîøåíèÿ ñ FDA èñïîëüçóþòñÿ Êñòàòè, ÷òî ïî ýòîìó ïîâîäó ïèøåò ìàëîèçâåñòíûé â ÑØÀ Harrison's Principles of Internal Medicine?

Öèòàòà:
The question arises whether glucosamine is "chondroprotective." Results of two recent randomized clinical trials have led to the suggestion that glucosamine not only improves joint pain in patients with knee OA1, but protects against articular cartilage damage, based upon analyses of changes in joint space width in the standing anteroposterior (AP) knee radiograph. However, concern has been expressed about the interpretation of the results of these studies because of limitations of the radiographic methods employed. A multicenter study supported by the National Institutes of Health, the Glucosamine Chondroitin Arthritis Intervention Trial (GAIT), is in progress which is comparing glucosamine, chondroitin sulfate, the combination, and celecoxib with placebo in patients with knee OA. Although the primary outcome measure is joint pain after 6 months of treatment, approximately 50% of the subjects will be maintained on treatment for 2 years and radiographs obtained at baseline will be compared with those obtained after 1 year and 2 years of treatment.

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr.Nikolaev îäîáðèë(à):
  #4  
Ñòàðûé 05.10.2006, 21:40
Àâàòàð äëÿ Sereda Andrey
Sereda Andrey Sereda Andrey âíå ôîðóìà
òðàâìàòîëîã-îðòîïåä
      
 
Ðåãèñòðàöèÿ: 04.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5,322
Ïîáëàãîäàðèëè 1,242 ðàç(à) çà 1,140 ñîîáùåíèé
Sereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïàñèáî, ïðèíÿë ê ñâåäåíèþ. Îñòàëîñü òîëüêî óáåäèòü ïàöèåíòîâ ïðèíèìàòü òåðàôëåêñ ïî 1 òàáëåòêå 2 ðàçà â äåíü 2 ãîäà êàæäûé äåíü. È ïðè ýòîì íå çàáûâàòü ïðî ïðåñòàðèóì, èíäàïàìèä, íåáèâîëîë, íèòðî-ìàçè-àïïëèêàòîðû, êîíòðîëü äàâëåíèÿ è ïóëüñà 4 ðàçà â äåíü, ñàõàð íå çàáóäüòå... Ãîðñòü íà çàâòðàê, íà îáåä, íà ïîëäíèê. "Äîêòîð, à îíè òî÷íî â æåëóäêå ðàñòâîðÿþòñÿ, à íå êîïÿòñÿ? " Íåõàé ôàðìãèãàíòû ïðèäóìàþò ïðîëîíãèðîâàííóþ ôîðìó, ÷òîá 1 ðàç â ìåñÿö, òîãäà ÿ óâèæó çåðíî ðàçóìà. À òàê íàçíà÷åíèå òåðàôëåêñà ñàìî ïî ñåáå ñëîæíî ðàñöåíèâàòü êàê íåîáõîäèìîñòü. Êàê áû íå âûðàáîòàòü êîìïëåêñ ñóïåðáîëüíîãî ó áîëüíîãî. Ìîæåò áûòü ó íàñ ïðåïàðàòû õîíäðîèòèíà ëåâûå? ïîðÿäêà 30 æàëîá â ìîèõ íàáëþäåíèÿõ íà òî, ÷òî ìîíîïðèåì "Ñòðóêòóì", "òåðàôëåêñ" íå ïðèíåñ îáëåã÷åíèÿ íó íè íà éîòó. Íåò, êîíå÷íî íå ðàíäîìèçèðîâàííîå èññëåäîâàíèå, íî íè îäíà ñòàòüÿ íèêîãäà íå óáåäèò ìåíÿ èñïîëüçîâàòü ìåòîä ëå÷åíèÿ, åñëè ÿ âèäåë çíà÷èìîå äëÿ ìåíÿ ÷èñëî íåóäà÷ ýòîãî ìåòîäà. Êîíå÷íî ÿ çàäóìàþñü (è ñâåðþñü) ñ îðèãèíàëüíîé òåõíîëîãèåé... Íî âñå æå, ìîæåò ó íàñ õîíäðîèòèí ëåâûé? À àìåðèêàíñêèé â íàøèõ êðàÿõ íå ïîïàäàëñÿ.
  #5  
Ñòàðûé 05.10.2006, 22:11
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Question

Öèòàòà:
Ñîîáùåíèå îò Sereda Andrey
Ñïàñèáî, ïðèíÿë ê ñâåäåíèþ. Îñòàëîñü òîëüêî óáåäèòü ïàöèåíòîâ ïðèíèìàòü òåðàôëåêñ ïî 1 òàáëåòêå 2 ðàçà â äåíü 2 ãîäà êàæäûé äåíü. È ïðè ýòîì íå çàáûâàòü ïðî ïðåñòàðèóì, èíäàïàìèä, íåáèâîëîë, íèòðî-ìàçè-àïïëèêàòîðû, êîíòðîëü äàâëåíèÿ è ïóëüñà 4 ðàçà â äåíü, ñàõàð íå çàáóäüòå... Ãîðñòü íà çàâòðàê, íà îáåä, íà ïîëäíèê. .
À êòî ñêàçàë, ÷òî ëå÷èòüñÿ - ïðîñòî?
  #6  
Ñòàðûé 06.10.2006, 02:38
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,837
Ïîáëàãîäàðèëè 33,439 ðàç(à) çà 31,782 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
A multicenter study supported by the National Institutes of Health, the Glucosamine Chondroitin Arthritis Intervention Trial (GAIT), is in progress which is comparing glucosamine, chondroitin sulfate, the combination, and celecoxib with placebo in patients with knee OA... (C) Harrison

Óæå:

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

"As compared with the rate of response to placebo (60.1 percent), the rate of response to combined treatment was 6.5 percentage points higher (P=0.09). The rate of response in the celecoxib control group was 10.0 percentage points higher than that in the placebo control group (P=0.008).
For patients with moderate-to-severe pain at baseline, the rate of response was significantly higher with combined therapy than with placebo (79.2 percent vs. 54.3 percent, P=0.002)."

Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain.

Êîíå÷íî, ïëàöåáî-ýôôåêò ïðîñòî ïîòðÿñàþùèé:

The study by Clegg et al. (Feb. 23 issue) suggests that glucosamine and chondroitin are not better than placebo for knee osteoarthritis. The most remarkable aspect of their study is perhaps the huge placebo effect — 60 percent of the patients noted at least a 20 percent decrease in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score from baseline to week 24. The authors comment that "elevated rates of response to placebo have been reported in other osteoarthritis trials." However, the two references provided did not show long-term placebo effects after oral medication — one used intraarticular injections and the other had only 13 weeks of follow-up. The extraordinary response to oral placebo in the trial by Clegg et al. might explain its findings. That is, if placebo is effective in 60 percent of patients, it is difficult for other treatments to surpass this mark. The use of rescue medication seems to have increased during the trial period in all groups. No data were provided on other concomitant treatments, such as physiotherapy. Was the improvement in the placebo group the result of treatment or a true placebo response?


Edzard Ernst, M.D., Ph.D.
Peninsula Medical School
Exeter EX2 4NT, United Kingdom

Âîò íàì áû òàêîå ÍÏÂÑ ïëàöåáî, êîòîðîå âñåãî íà 10% óñòóïàåò öåëåêîêñèáó 200 - íèêàêèõ òåáå íè ÿçâ/ÿçâåííûõ êðîâîòå÷åíèé, íè ïîâûøåíèÿ ðèñêà ÈÁÑ

Åñëè ïðèìåíÿòü "äîêàçàòåëüñòâà îò ïðîòèâíîãî", òî ñî÷åòàííîå ëå÷åíèå õîíäðî-ãëþêî (500 mg of glucosamine plus 400 mg of chondroitin sulfate three times daily) âñåãî íà 3,5% áûëî õóæå, ÷åì öåëåêîêñèáîì. Èíòåðåñíî, êàê òàì ïî öåíå 2,7 ã õîíäðî-ãëþêî â ñóòêè ïðîòèâ 0,2 öåëåêî: ó êîãî ïî íàøèì öåíàì cost-effifacy âûøå?

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr. îäîáðèë(à): ýòî áîäðèò
Rodionov îäîáðèë(à):
SergeyPlyasunov îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
  #7  
Ñòàðûé 09.10.2006, 16:58
Àâàòàð äëÿ pepp
pepp pepp âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.08.2006
Ãîðîä: Israel
Ñîîáùåíèé: 1,030
Ïîáëàãîäàðèëè 49 ðàç(à) çà 47 ñîîáùåíèé
pepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpepp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Sereda Andrey
Ïðîèçâîäèòåëü ðåêîìåíäóåò ïðèíèìàòü ïðåïàðàò äëèòåëüíî.... ò.å. ïîñòîÿííî. Íå ñåêðåò, ÷òî òàêèì îáðàçîì ïîëó÷àÿ ôèíàíñîâóþ âûãîäó. Íî! Ïîìíèòå î òîì, ÷òî ïðèìåíèòåëüíî ê ýòîìó "ëåêàðñòâó" ÎÒÑÓÒÑÒÂÓÞÒ âíÿòíûå äîêàçàòåëüñòâà ýôôåêòèâíîñòè ïðè ðàçëè÷íûõ âàðèàíòàõ ïðèìåíåíèÿ. ß íèêîãäà íå íàçíà÷àþ ñâîèì ïàöèåíòàì Òåðàôëåêñ è åãî "îäíîãðóïïíèêîâ". Âðà÷è â ÑØÀ âîîáùå íå çíÿþò- ÷òî òàêîå õîíäðîïðîòåêòîð. Âîò è ä-ð Ðåðð íà ìîé íåäàâíèé âîïðîñ î òîì, ÷òî îí ïîíèìàåò ïîä õîíäðîïðîòåêòîðàìè, îòâåòèë, ÷òî õîíäðîïðîòåêòèâíîå äåéñòâèå èìïëàíòàòîâ ñèíîâèàëüíîé æèäêîñòè. ( à íå òàáëåòîê õîíäðîèòèí ñóëüôàòà è ò.ä.) Ñîáñòâåííî ãîâîðÿ ïîäîáíàÿ ïàíàöåÿ "îò ñóñòàâîâ" ïðîäàåòñÿ íàãëûì îáðàçîì (ãäå ðîññèéñêàÿ FDA?!?) íà òåððèòîðèè áûâøåãî ÑÑÑÐ. Ëó÷øå äîëîæèòå ñóòü âàøåé ïðîáëåìû ñîãëàñíî ïðàâèëàì ôîðóìà. Òîãäà ñîâåò, âîçìîæíî, áóäåò ïðàêòè÷íåå.

Óâàæàåìûé Àíäðåé.
Ïðåïàðàòû, îñíîâàííûå íà ïðîòàìèí è õîíîäðîèòèí ñóëüôàò, íå ÿâëÿþòñÿ õîíäðîïðîòåêòîðàìè.
Õîíäðîèòèí -ýòî åñëè ÿ íå îøèáàþñü ñîñòàâëÿþùåå ïðîòåîãëèêàíîâ, îðãàíèçóþùèåñÿ â ãëþêîçàìèí è ÿâëÿþùååñÿ îñíîâîé õðÿùà.
ß ïîëüçîâàëñÿ íåñêîëüêèìè èç íèõ. Ýòî Êàðòèëÿãî, Ìåãàãëþôëåêñ è ïð. Íà ñâîåì îïûòå, äà è ðàçãîâàðèâàÿ ñ äðóãèìè îðòîïåäàìè, èç âñåé ãðóïïû ýòèõ ïðåïàðàòîâ ëó÷øèé ýòî ÊÎÇÀÌÈÍ. Îïÿòü æå ýòî íàøå ëè÷íîå ìíåíèå.
Èíîãäà ïðèìåíÿåøü ýòè ïðåïàðàòû è îíè íå ïîìîãàþò. Ìåíÿåøü ïðåïàðàò íà ÊÎÇÀÌÈÍ ÄÈ ÑÈ, è áîëè óõîäÿò.

 ëþáîì ñëó÷àå, ó ïàöèåíòîâ ñ 4 ñòàäèåé àðòðèòà ýòî íå äåéñòâóåò îäíîçíà÷íî.  ëèòåðàòóðå òàê è îïèñûâàåòñÿ, ïðèìåíÿòü â ðàííèõ ñòàäèÿõ àðòðèòà.

ß æå ïðèìåíÿþ ýòè ïðåïàðàòû òàêèì îáðàçîì. Åñëè ÷åëîâåê íå ðåàãèðóåò íà ïðèìåíåíèå ïðåïàðàòà, òî ÷åðåç 3 ìåñÿöà ãîâîðþ åìó, ÷òî áû ïðåêðàùàë. Äàëüøå òîëêó íå áóäåò, Ýòî äîñòàòî÷íîå âðåìÿ ÷òî áû ïîíÿòü, ðàáîòàåò ïðåïàðàò èëè íåò.

Êñòàòè, êòî-òî çäåñü ïðîèçíåñ, ÷òî ÕÀÐÈÑÎÍ ÈÍÒÅÐÍÀË ÌÅÄÈÑÈÍ ýòî êíèãà íå ïðèçíàâàåìàÿ â ÑØÀ. Ãîñïîäà-ýòî íàñòîëüíûé ó÷åáíèê âñåõ òåðàïåâòîâ è íå òîëüêî, íî è ìíîãèõ äðóãèõ ñïåöèàëüíîñòåé â Øòàòàõ. Ó÷åáíèê îáúåäèíÿåò âñå çàáîëåâàíèÿ, êîòîðûå òîëüêî ìîæíî, ëó÷øåãî ÿ íå âñòðå÷àë. Ñåãîäíÿ îí ÿâëÿåòñÿ ó÷åáíèêîì íîìåð 1 è â åâðîïåéñêèõ ñòðàíàõ.

Êîììåíòàðèè ê ñîîáùåíèþ:
Tim Vetrov îäîáðèë(à): Ñïàñèáî. Ïî ïîâîäó Õàðèñîíà - ýòî øóòêà.
  #8  
Ñòàðûé 09.10.2006, 17:55
Dem Dem âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.09.2006
Ñîîáùåíèé: 15
Dem *
Âû ìåæäó ñîáîé ðàçãîâàðèâàåòå?...
  #9  
Ñòàðûé 09.10.2006, 18:03
Àâàòàð äëÿ Sereda Andrey
Sereda Andrey Sereda Andrey âíå ôîðóìà
òðàâìàòîëîã-îðòîïåä
      
 
Ðåãèñòðàöèÿ: 04.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5,322
Ïîáëàãîäàðèëè 1,242 ðàç(à) çà 1,140 ñîîáùåíèé
Sereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
2 DEM Îòâåò íà âîïðîñ, çðÿ ëè Âû ïðèíèìàëè òåðàôëåêñ- èùèòå â äèñêóññèè. Íà âîïðîñ î ñãèáàòåëüíîé êîíòðàêòóðå ïî òàêîé ñêóäíîé èíôîðìàöèè ñêàçàòü âîîáùå íè÷åãî íåëüçÿ.
2 Ðåðð- ñïàñèáî.
  #10  
Ñòàðûé 09.10.2006, 18:06
Àâàòàð äëÿ Sereda Andrey
Sereda Andrey Sereda Andrey âíå ôîðóìà
òðàâìàòîëîã-îðòîïåä
      
 
Ðåãèñòðàöèÿ: 04.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5,322
Ïîáëàãîäàðèëè 1,242 ðàç(à) çà 1,140 ñîîáùåíèé
Sereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSereda Andrey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïî ïîâîäó ìàëîèçâåñòíîãî ÕÈÌ ÿâíî ïî-äîáðîìó ñúÿçâèëè.
  #11  
Ñòàðûé 16.02.2007, 13:33
Mystical Mystical âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 11.02.2007
Ãîðîä: Íàðî-Ôîìèíñê
Ñîîáùåíèé: 15
Mystical *
Öèòàòà:
Ñîîáùåíèå îò Sereda Andrey
Ïðîèçâîäèòåëü ðåêîìåíäóåò ïðèíèìàòü ïðåïàðàò äëèòåëüíî.... ò.å. ïîñòîÿííî. Íå ñåêðåò, ÷òî òàêèì îáðàçîì ïîëó÷àÿ ôèíàíñîâóþ âûãîäó. Íî! Ïîìíèòå î òîì, ÷òî ïðèìåíèòåëüíî ê ýòîìó "ëåêàðñòâó" ÎÒÑÓÒÑÒÂÓÞÒ âíÿòíûå äîêàçàòåëüñòâà ýôôåêòèâíîñòè ïðè ðàçëè÷íûõ âàðèàíòàõ ïðèìåíåíèÿ. ß íèêîãäà íå íàçíà÷àþ ñâîèì ïàöèåíòàì Òåðàôëåêñ è åãî "îäíîãðóïïíèêîâ". Âðà÷è â ÑØÀ âîîáùå íå çíÿþò- ÷òî òàêîå õîíäðîïðîòåêòîð. Âîò è ä-ð Ðåðð íà ìîé íåäàâíèé âîïðîñ î òîì, ÷òî îí ïîíèìàåò ïîä õîíäðîïðîòåêòîðàìè, îòâåòèë, ÷òî õîíäðîïðîòåêòèâíîå äåéñòâèå èìïëàíòàòîâ ñèíîâèàëüíîé æèäêîñòè. ( à íå òàáëåòîê õîíäðîèòèí ñóëüôàòà è ò.ä.) Ñîáñòâåííî ãîâîðÿ ïîäîáíàÿ ïàíàöåÿ "îò ñóñòàâîâ" ïðîäàåòñÿ íàãëûì îáðàçîì (ãäå ðîññèéñêàÿ FDA?!?) íà òåððèòîðèè áûâøåãî ÑÑÑÐ. Ëó÷øå äîëîæèòå ñóòü âàøåé ïðîáëåìû ñîãëàñíî ïðàâèëàì ôîðóìà. Òîãäà ñîâåò, âîçìîæíî, áóäåò ïðàêòè÷íåå.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - ïî÷åìó íå ìîæåò ÿâëÿòüñÿ âíÿòíûì äîêàçàòåëüñòâîì
  #12  
Ñòàðûé 16.02.2007, 20:18
zaitsev zaitsev âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.11.2002
Ãîðîä: Òîëüÿòòè
Ñîîáùåíèé: 1,337
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 87 ðàç(à) çà 87 ñîîáùåíèé
zaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåzaitsev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èññëåäîâàíèå, íà êîòîðîå Âû ññûëàåòåñü - ìÿãêî ãîâîðÿ, ñîäåðæèò ìíîãî íåäîñòàòêîâ â ñâåì äèçàéíå è íå ìîæåò ñ÷èòàòüñÿ îáúåêòèâíûì.
  #13  
Ñòàðûé 17.02.2007, 11:46
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
  #14  
Ñòàðûé 02.08.2008, 09:07
Annar Annar âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
 
Ðåãèñòðàöèÿ: 21.04.2008
Ãîðîä: Ñòàâðîïîëü
Ñîîáùåíèé: 23
Annar ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Ïåðâîå ëå÷åíèå íà÷àëîñü 8 ëåò íàçàä è çàòåì âî âîçðàñòàþùåé: îò äèêëîôåíàêà, ñ 1 òàáë, îðòîôíåà îò 1 ò., à çàêîí÷èëà ïî 7 øò â äåíü !!!, Êàæäûå ïîëãîäà - â ñòàöèîíàðå, èí"åêöèè â êîëåííûé ñóñòàâ - àëôëóòîï, õîíäðîëîí, ðóìàëîí, êñåôîêàì, óëó÷øåíèÿ ìàêñèìóì íà 1 ìåñ. Çàòåì è ýòî íå ïîìîãàëî, ïåðåøëà íà ïàëî÷êó ( â50 ëåò!!), ñîêðàòèëà ïîëíîñòüþ ïåðåäâèæåíèÿ, áîëè, ìó÷åíèÿ â äâèæåíèè íå äëÿ õîäüáû, ïîíÿëà, ÷òî âñå èäåò ê îáåçäâèæèâàíèþ.....
À âîò õèðóðãè âåðíóëè ðàäîñòü äâèæåíèÿ, òåïåðü ýòî öåíèòñÿ îñîáî!! Êîíå÷íî, â êîíöå äíÿ ÷óâñòâóåòñÿ áîëåçíåííîñòü, óñòàëîñòü íîã, íî ýòî âñå ìåëî÷è, â ñðàâíåíèè ñ òåì, ÷òî áûëî.
ß ïðåäóïðåæäàþ âñåõ - ÍÅ ÏÎÄÄÀÂÀÉÒÅÑÜ ÍÀ ÐÅÊËÀÌÛ ÏÎ ÐÀÄÈÎ,ÍÅ ÒÐÀÒÜÒÅ ÇÐß ÑÂÎÈ ÄÅÍÜÃÈ ÍÀ ÁÀÄÛ!
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 20:26.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.